ChiHeal Bio Special Forum Successfully Held in Nanjing, Gathering Industry Experts to Explore Future Innovations

On February 27, 2025, the ChiHeal Bio Special Forum was successfully held at the Fengda International Hotel in Nanjing. Under the theme “Focusing on Innovation, Analyzing Policy Concepts, and Shaping the Future of Enterprises,” the event attracted numerous industry experts, scholars, and business leaders. Together, they explored cutting-edge trends and emerging opportunities in the pharmaceutical sector.

I. Leadership Address: Kicking Off the Event and Envisioning the Future

At the beginning of the conference, Wang Jinlong, Executive Vice President of the Hebei Pharmaceutical Regulatory Association and former First-Level Inspector and Deputy Director of the Hebei Provincial Drug Administration, took the stage to officially inaugurate the event. Speaking from the perspective of industry regulation, Mr. Wang emphasized the guiding role of policies in the development of the pharmaceutical sector. He urged enterprises to proactively embrace policy changes and leverage innovation as a driving force to promote high-quality industry growth.

Following this, Dr. Zhang Zhefeng, Chairman of ChiHeal Bio, delivered an inspiring speech. Dr. Zhang warmly welcomed the esteemed guests and provided a brief overview of ChiHeal Bio’s achievements and explorations in pharmaceutical innovation. He also outlined the company’s ambitious vision for the future of the industry.

The speeches from both leaders laid a solid foundation for the forum and offered valuable insights to all attendees.

II. Academic Reports: Intellectual Exchange and Cutting-Edge Insights

Dr. Zhang Zhefeng, Chairman of ChiHeal Bio, Professor Yang Jin from the Department of Pharmacology at China Pharmaceutical University, Senior Strategic Partner for Greater Bay Area Registration at ChiHeal Bio, Shi Hanzhong, Professor Wang Shujun, an expert from the National Medical Products Administration, Professor Wang Zhisen, a foreign academician of the Russian Academy of Engineering, Mr. Guo Xinfeng, Founder of Nanjing Evidence-Based Biotechnology Co., Ltd., and Mr. Wang Hailin, Founder of the Pharma Screening WeChat account, each delivered in-depth presentations on critical topics such as drug research and development under the new centralized procurement policy, the development of the health industry in Macau, the direction of the pharmaceutical sector, and new drug project initiation. Their discussions provided attendees with comprehensive, multi-dimensional industry insights.

Liu Tianshuo, Founding Partner of Jinyu Virtual Image, focused on the topic of reinforcement learning in modern AI systems, presenting attendees with cutting-edge academic concepts from the international forefront. Dr. Ding Wei, Chief Scientist of Peptides at ChiHeal Bio, Director of the AI Center, and AI Exchange Scholar at the University of Macau, provided an in-depth analysis of the application of the artificial intelligence software DeepSeek in the biopharmaceutical field. He showcased the limitless possibilities of integrating technology with the pharmaceutical industry.

III. Roundtable Discussion: In-Depth Exploration and Collaborative Development

The roundtable session elevated the forum’s discussion to its peak. The first roundtable discussion, themed “The Future Development of China’s Pharmaceutical Industry Under Current Policies and On-Site Discussion and Q&A on Hong Kong and Macau Registration,” featured Dr. Zhang Zhefeng, Professor Wang Shujun, Professor Yang Jin, Shi Hanzhong, Dai Yabing, Li Keming, Feng Xuelun, and Du Xiaozhou. They engaged in lively discussions on key topics such as policy direction, industry trends, and Hong Kong and Macau registrations. The session provided valuable insights and answered attendees' questions, offering pharmaceutical companies significant references for their development.

Next, the second roundtable discussion focused on “Ideas and Opportunities in the Initiation and Development of Traditional Chinese Medicine Projects.” Dr. Zhang Zhefeng, Guo Xinfeng, Professor Wang Zhisen, Cui Yi, Zhao Dongming, and Shi Hanzhong explored the development opportunities and challenges faced by Traditional Chinese Medicine (TCM) in the new era from various perspectives. They provided clear direction and insights for the initiation and development of TCM projects. The deep exchanges and intellectual collisions during both roundtable discussions offered new ideas and directions for the future development of the pharmaceutical industry.

IV. Project Promotion: Showcasing Strength and Expanding Cooperation

Zhao Dongming, President of Shijiazhuang Diskeyway Pharmaceutical Technology Co., Ltd., Zuo Wenfei, General Manager and Director of the Traditional Chinese Medicine Research Institute, Sun Dongfang, Director of the Research Institute at ChiHeal (Shandong) Pharmaceuticals, Shi Wenxiang, Business Director at Nanjing ChiHeal Bio, Fu Haijian, Director of the Innovation Drug Division and Director of the Molecular Design Research Institute, and Tian Xueqin, Business Manager, each delivered insightful presentations on ChiHeal Bio’s innovative drug projects, Traditional Chinese Medicine initiatives, large-scale pharmaceutical operations and collaboration models, as well as generic drug projects. They showcased the company’s R&D strengths and innovative achievements in various fields, offering abundant collaboration opportunities for attending enterprises and further expanding ChiHeal Bio’s business footprint.

V. On-Site Interaction: Packed with Enthusiasm, Hot Cooperation

From February 27 to 28, ChiHeal Bio’s booth became one of the most popular spots at the forum. The booth was bustling with activity as representatives from pharmaceutical companies, experts, and scholars from across the country gathered to discuss projects and explore cooperation opportunities. The vibrant atmosphere at the booth highlighted ChiHeal Bio’s strong influence and appeal within the industry, providing an excellent platform for project promotion and business expansion.

VI. A Complete Success: Opening a New Chapter and Building a Collaborative Ecosystem

The ChiHeal Bio Special Forum concluded successfully amid a vibrant atmosphere. The successful hosting of the event not only provided a platform for in-depth exchange and learning for professionals in the pharmaceutical industry but also injected new vitality into ChiHeal Bio's business development, opening a new chapter for the company.

Attendees delved deeply into hot topics such as artificial intelligence, the internationalization of innovative drugs, Hong Kong and Macau registrations, and innovations in Traditional Chinese Medicine. ChiHeal Bio's exclusive Hong Kong and Macau registration agency shared successful experiences, engaged in on-site interactions, and answered participants' questions. Furthermore, ChiHeal Bio introduced new development measures through its diversified CXO services and packaged offerings. By leveraging its comprehensive CRO, CMO, CSO, and CRDMO service advantages, ChiHeal Bio aims to reduce clients' R&D costs. Additionally, ChiHeal (Shandong) Pharmaceuticals unveiled its groundbreaking "Zero Processing Fee" collaboration model!

In the future, ChiHeal Bio will continue to uphold its innovative理念, focus on cutting-edge fields, and work hand in hand with its numerous partners to build a new ecosystem of collaboration within the pharmaceutical industry. The company is committed to contributing even more to the high-quality development of the pharmaceutical sector and writing a brighter and more glorious future chapter!